Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-15,000
Closed -$1.86M 2143
2023
Q4
$1.86M Buy
+15,000
New +$1.53M 0.01% 821

Other funds holding DXCM

Steve Schonfeld's DXCM Position: Q2 2026 in Review

Steve Schonfeld increased its DexCom (DXCM) stake by 90% in Q2 2026, buying an estimated $9.2M and bringing the position to 291,053 shares worth $19.6M. The position accounts for 0.07% of the portfolio, ranked #252.

Steve Schonfeld first reported a position in DXCM in Q4 2016 and has held it in 38 quarters since. The position peaked at $28.3M in Q3 2023. 966 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Steve Schonfeld held 291,053 shares of DexCom worth $19.6M as of Q2 2026.
  • Steve Schonfeld bought 138,123 DexCom shares in Q2 2026, an estimated $9.2M.
  • DexCom made up 0.07% of Steve Schonfeld's portfolio in Q2 2026, its #252 holding.
  • Steve Schonfeld first reported a position in DexCom in Q4 2016 and has held it in 38 quarters since.
  • Steve Schonfeld's DexCom position peaked at $28.3M in Q3 2023.
  • 966 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.